|
|
|
|
LEADER |
01000cam a22002652 4500 |
001 |
1773183230 |
003 |
DE-627 |
005 |
20230428011910.0 |
007 |
cr uuu---uuuuu |
008 |
211011s2020 xx |||||o 00| ||eng c |
035 |
|
|
|a (DE-627)1773183230
|
035 |
|
|
|a (DE-599)KEP068720041
|
035 |
|
|
|a (NCBI)1774827
|
035 |
|
|
|a (EBP)068720041
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
041 |
|
|
|a eng
|
110 |
2 |
|
|a CADTH Canadian Drug Expert Committee,
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a CADTH Canadian Drug Expert Committee recommendation
|b indication: systemic lupus erythematosus (SLE)Belimumab (Benlysta subcutaneous [SC] -- GlaxoSmithKline Inc.)
|
264 |
|
1 |
|a Ottawa (ON)
|b CADTH
|c April 2020
|
300 |
|
|
|a 1 online resource (1 PDF file (8 pages)).
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a CADTH common drug review
|
500 |
|
|
|a Description based on online resource; title from PDF title page (viewed March 15, 2021)
|
650 |
|
2 |
|a Lupus Erythematosus, Systemic
|x drug therapy
|0 https://id.nlm.nih.gov/mesh/D008180Q000188
|
650 |
|
2 |
|a Immunosuppressive Agents
|x therapeutic use
|0 https://id.nlm.nih.gov/mesh/D007166Q000627
|
650 |
|
2 |
|a Antibodies, Monoclonal, Humanized
|x therapeutic use
|0 https://id.nlm.nih.gov/mesh/D061067Q000627
|
650 |
|
2 |
|a Immunosuppressive Agents
|x economics
|0 https://id.nlm.nih.gov/mesh/D007166Q000191
|
650 |
|
2 |
|a Cost-Benefit Analysis
|0 https://id.nlm.nih.gov/mesh/D003362
|
650 |
|
2 |
|a Insurance, Health, Reimbursement
|0 https://id.nlm.nih.gov/mesh/D007349
|
651 |
|
2 |
|a Canada
|0 https://id.nlm.nih.gov/mesh/D002170
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK564604/
|m X:NCBI
|x Verlag
|z teilw. kostenfrei
|
912 |
|
|
|a ZDB-193-NCB
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a ISIL_DE-18
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_22_i06404
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a ISIL_DE-7
|
912 |
|
|
|a GBV_ILN_74
|
912 |
|
|
|a ISIL_DE-354
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a ISIL_DE-25
|
912 |
|
|
|a GBV_ILN_2009
|
912 |
|
|
|a ISIL_DE-180
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a ISIL_DE-15
|
951 |
|
|
|a BO
|
980 |
|
|
|2 22
|1 01
|x 0018
|b 3994080347
|h h64 NCBI
|y zi06404
|z 21-10-21
|
980 |
|
|
|2 40
|1 01
|x 0007
|b 3994006597
|h OLR-NCB-BOOKSHELF
|y xsn
|z 21-10-21
|
980 |
|
|
|2 74
|1 01
|x 0354
|b 3999782862
|c 09
|f E-Bibl
|d EM 0000
|e --%%--
|j --%%--
|y ze
|z 08-11-21
|
980 |
|
|
|2 2003
|1 01
|x DE-25
|b 3995675476
|c 00
|f --%%--
|d --%%--
|e --%%--
|j n
|k Elektronischer Volltext - Open Access
|y l01
|z 25-10-21
|
980 |
|
|
|2 2009
|1 01
|x DE-180
|b 3987672757
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|y l01
|z 11-10-21
|
980 |
|
|
|2 2010
|1 01
|x DE-15
|b 3987761792
|c 00
|f --%%--
|d --%%--
|e --%%--
|j n
|k Elektronischer Volltext - Open Access
|y l01
|z 11-10-21
|
981 |
|
|
|2 22
|1 01
|x 0018
|r https://www.ncbi.nlm.nih.gov/books/NBK564604/
|
981 |
|
|
|2 40
|1 01
|x 0007
|y Volltext, Open Access
|r https://www.ncbi.nlm.nih.gov/books/NBK564604/
|
981 |
|
|
|2 74
|1 01
|x 0354
|r https://www.ncbi.nlm.nih.gov/books/NBK564604/
|
981 |
|
|
|2 2003
|1 01
|x DE-25
|r https://www.ncbi.nlm.nih.gov/books/NBK564604/
|
981 |
|
|
|2 2010
|1 01
|x DE-15
|y Online-Zugriff
|r https://www.ncbi.nlm.nih.gov/books/NBK564604/
|
985 |
|
|
|2 22
|1 01
|x 0018
|a h64 ebook
|
985 |
|
|
|2 74
|1 01
|x 0354
|a EM 0000
|
995 |
|
|
|2 22
|1 01
|x 0018
|a h64 NCBI
|
995 |
|
|
|2 22
|1 01
|x 0018
|a h64 freie Ressource
|
995 |
|
|
|2 40
|1 01
|x 0007
|a OLR-NCB-BOOKSHELF
|